Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
Public ClinicalTrials.gov record NCT00140348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine in Patients With Metastatic Hormone-Refractory Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum tolerated dose.
Study identification
- NCT ID
- NCT00140348
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Apr 2005 (Actual)
- Last update posted
- Dec 24, 2007
2001 – 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| South Orange County Medical Research Center | Laguna Woods | California | 92637 | — |
| UCSF | San Francisco | California | 94115 | — |
| West Coast Clinical Research | Tarzana | California | 91356 | — |
| South Florida Medical Research | Aventura | Florida | 33180 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Northeast Indiana Research | Fort Wayne | Indiana | 46825 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109 | — |
| Fox Chase cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Urology San Antonio | San Antonio | Texas | 78229 | — |
| Virginia Mason Med. Crt. | Seattle | Washington | 98101 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00140348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 24, 2007 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00140348 live on ClinicalTrials.gov.